Drug Shortage Report for GD-VENLAFAXINE XR
Report ID | 27249 |
Drug Identification Number | 02360039 |
Brand name | GD-VENLAFAXINE XR |
Common or Proper name | VENLAFAXINE |
Company Name | GENMED A DIVISION OF PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 75MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 90s |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-12-18 |
Estimated end date | |
Actual end date | 2018-01-24 |
Shortage status | Resolved |
Updated date | 2018-01-25 |
Company comments | Other presentations available: GD-Venlafaxine 37.5mg |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-10-27 | English | Compare |
v2 | 2017-10-27 | French | Compare |
v3 | 2017-11-07 | English | Compare |
v4 | 2017-12-14 | English | Compare |
v5 | 2017-12-14 | French | Compare |
v6 | 2017-12-18 | English | Compare |
v7 | 2017-12-18 | English | Compare |
v8 | 2017-12-18 | French | Compare |
v9 | 2017-12-19 | English | Compare |
v10 | 2017-12-20 | English | Compare |
v11 | 2017-12-20 | English | Compare |
v12 | 2017-12-20 | French | Compare |
v13 | 2018-01-05 | English | Compare |
v14 | 2018-01-05 | French | Compare |
v15 | 2018-01-11 | English | Compare |
v16 | 2018-01-11 | French | Compare |
v17 | 2018-01-24 | English | Compare |
v18 | 2018-01-24 | French | Compare |
v19 | 2018-01-25 | English | Compare |
Showing 1 to 19 of 19